231 related articles for article (PubMed ID: 36674794)
1. Hyperforin Elicits Cytostatic/Cytotoxic Activity in Human Melanoma Cell Lines, Inhibiting Pro-Survival NF-κB, STAT3, AP1 Transcription Factors and the Expression of Functional Proteins Involved in Mitochondrial and Cytosolic Metabolism.
Cardile A; Zanrè V; Campagnari R; Asson F; Addo SS; Orlandi E; Menegazzi M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674794
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers.
Cardile A; Passarini C; Zanrè V; Fiore A; Menegazzi M
Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507910
[TBL] [Abstract][Full Text] [Related]
3. Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability.
Raineri A; Fasoli S; Campagnari R; Gotte G; Menegazzi M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783660
[TBL] [Abstract][Full Text] [Related]
4. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
Gambichler T; Harnischfeger F; Skrygan M; Majchrzak-Stiller B; Buchholz M; Müller T; Braumann C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895015
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in melanoma A375 cells by a chloroform fraction of Centratherum anthelminticum (L.) seeds involves NF-kappaB, p53 and Bcl-2-controlled mitochondrial signaling pathways.
Looi CY; Moharram B; Paydar M; Wong YL; Leong KH; Mohamad K; Arya A; Wong WF; Mustafa MR
BMC Complement Altern Med; 2013 Jul; 13():166. PubMed ID: 23837445
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.
De Tomi E; Campagnari R; Orlandi E; Cardile A; Zanrè V; Menegazzi M; Gomez-Lira M; Gotte G
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163570
[TBL] [Abstract][Full Text] [Related]
10. Salviolone from
Zanrè V; Campagnari R; Cerulli A; Masullo M; Cardile A; Piacente S; Menegazzi M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163058
[TBL] [Abstract][Full Text] [Related]
11. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
Liu Q; Mier JW; Panka DJ
Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745
[TBL] [Abstract][Full Text] [Related]
12. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
13. NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.
Kaoud TS; Mohassab AM; Hassan HA; Yan C; Van Ravenstein SX; Abdelhamid D; Dalby KN; Abdel-Aziz M
Eur J Med Chem; 2020 Jan; 186():111885. PubMed ID: 31784187
[TBL] [Abstract][Full Text] [Related]
14. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.
Zanrè V; Bellinato F; Cardile A; Passarini C; Monticelli J; Di Bella S; Menegazzi M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338893
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Activity of
Menegazzi M; Masiello P; Novelli M
Antioxidants (Basel); 2020 Dec; 10(1):. PubMed ID: 33379141
[TBL] [Abstract][Full Text] [Related]
17. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
Shankar E; Zhang A; Franco D; Gupta S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208611
[TBL] [Abstract][Full Text] [Related]
18. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.
Yang J; Amiri KI; Burke JR; Schmid JA; Richmond A
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):950-60. PubMed ID: 16467110
[TBL] [Abstract][Full Text] [Related]
19. The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells.
Plitzko B; Kaweesa EN; Loesgen S
J Biol Chem; 2017 Dec; 292(51):21102-21116. PubMed ID: 29074620
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.
Gao Z; Shang Q; Liu Z; Deng C; Guo C
Oncotarget; 2015 Nov; 6(34):36338-53. PubMed ID: 26462148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
